Skip to content
mda-logo_stacked-all white
  • Subscribe
  • Newsletter
  • Advertise
  • MDA.org
  • Donate
Ques_media_logo

Ques_media_logo
Subscribe
Donate

  • Magazine
    • Current Issue
    • Past Issues
  • Featured Content
  • Topics
    • Advocacy
    • Finding a Diagnosis
    • Get Involved
    • Health
    • Inclusion
    • Independence
    • Lifestyle
    • News
    • Personal Stories
    • Science + Research
  • Diseases A-Z
  • Blog
  • Podcast
  • Product Guide
  • Career Quest

Clinical Trials

Blog Post

Simply Stated: What is Myotonic Dystrophy?

By Sujatha Gurunathan | March 24, 2022
Clinical & Scientific Conference
Blog Post

2022 Clinical & Scientific Conference: March 16 Highlights

By Sujatha Gurunathan | March 16, 2022
dystrophin
Blog Post

Simply Stated: What is Duchenne Muscular Dystrophy?

By Sujatha Gurunathan | February 16, 2022
Featured Article

A New Direction for Charcot-Marie-Tooth Disease

By MDA Staff | February 16, 2022
Blog Post

Simply Stated: What is Becker Muscular Dystrophy?

By Sujatha Gurunathan | January 6, 2022
Blog Post

FDA Approves argenx’s Vyvgart for Treatment of gMG

By Sujatha Gurunathan | December 20, 2021
Blog Post

Clinical Trial Alert: Early Phase Study of SRP-9001 in Boys with DMD

By Sujatha Gurunathan | November 9, 2021
Blog Post

Clinical Trial Alert: Phase 2/3 Study of Tideglusib (AMO-02) in Children and Adolescents with Congenital Myotonic Dystrophy

By Sujatha Gurunathan | November 9, 2021
Blog Post

Clinical Trial Alert: Phase 3b Study of Oral Edaravone in Adults with ALS

By Sujatha Gurunathan | October 11, 2021
Blog Post

Research Study Alert: Observational Study of Clinical and Electrophysiological Outcomes in Adults with CMT

By Sujatha Gurunathan | October 11, 2021
  • « Previous
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 19
  • Next »
  • Media
  • Careers
  • Donate
  • Contact Quest
muscular-dystrophy-association
Muscular Dystrophy Association, Inc.
1016 W Jackson Blvd #1073
Chicago, IL 60607
800-572-1717 | ResourceCenter@mdausa.org

 

Manage Your Quest Media Subscriptions










The Muscular Dystrophy Association (MDA) is a qualified 501(c)(3) tax-exempt organization. ©2022, Muscular Dystrophy Association Inc. All rights reserved.

Privacy Policy | Terms of Use | State Fundraising Notices

Skip to content
Open toolbar Accessibility Tools

Accessibility Tools

  • Increase TextIncrease Text
  • Decrease TextDecrease Text
  • GrayscaleGrayscale
  • High ContrastHigh Contrast
  • Negative ContrastNegative Contrast
  • Light BackgroundLight Background
  • Links UnderlineLinks Underline
  • Readable FontReadable Font
  • Reset Reset